Atrás
Rango del Día
$93.91
$96.86
Rango de 52 Semanas
$55.54
$113.02
Volumen
405,906
Promedio 50D / 200D
$102.59
/
$91.47
Cierre Anterior
$96.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -16.5 | 0.3 |
| P/B | 5.6 | 2.9 |
| ROE % | -36.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$137.44
+42.9%
Low: $120.00
High: $155.00
EPS Futuro
-$5.56
Ingresos Est.
14 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$6.16
$1.30 – $12.24
|
1.3 B | 5 |
| FY2029 |
$3.26
$0.69 – $6.48
|
930 M | 10 |
| FY2028 |
-$0.93
-$4.47 – $2.94
|
530 M | 12 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -275.21M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-36.70%
ROIC-24.89%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio15.27
Interest Coverage0.00
Valoración
P/E Ratio
-16.54
P/B Ratio5.64
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -425.38M |
| ROE | -36.70% | ROA | -30.11% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -275.21M |
| ROIC | -24.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 15.27 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -16.54 | P/B Ratio | 5.64 |
| P/S Ratio | N/A | PEG Ratio | -0.35 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 7.04B | Enterprise Value | 6.77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -425.38M | -260.76M | -126.22M | -81.85M | -46.34M |
| EPS (Diluted) | -5.85 | -3.93 | -2.17 | -1.65 | -2.13 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -414.31M | -280.37M | -149.49M | -86.11M | -45.82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.41B | 1.14B | 732.38M | 482.46M | 293.82M |
| Total Liabilities | 164.37M | 71.96M | 31.82M | 19.48M | 8.79M |
| Shareholders' Equity | 1.25B | 1.07B | 700.56M | 462.98M | 285.04M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 261.75M | 145.69M | 335.39M | 241.81M | 68.53M |
| Current Assets | 1.39B | 1.13B | 726.49M | 477.99M | 290.63M |
| Current Liabilities | 91.17M | 54.02M | 31.82M | 19.48M | 8.79M |